ATE73677T1

Transcutaneous therapeutic device; use and preparation thereof

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 20 August 2007, 19.1 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

59 members in 26 offices

This recordMember, by publication datePriority claim16 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
3629304GermanyA

Members59

Family members, oldest first
DocumentOfficeKind
PT85603APortugalA
IL83668A0IsraelA0
IL83668D0IsraelD0
ZA876388BSouth AfricaB
IE872291LIrelandL
WO8801516A1World Intellectual Property Organization (WIPO)A1
AU7803587AAustraliaA
DE3629304A1GermanyA1
EP0261402A1European Patent Office (EPO)A1
NO882136D0NorwayD0
DK270088ADenmarkA
DK270088D0DenmarkD0
FI882417AFinlandA
FI882417A0FinlandA0
FI882417LFinlandL
NO882136LNorwayL
NO912851LNorwayL
PL267473A1PolandA1
DE3629304C2GermanyC2
JPH01503706AJapanA
DD274975A5German Democratic Republic (until 1990)A5
NZ221600ANew ZealandA
PT85603BPortugalB
AU606885B2AustraliaB2
YU158787AYugoslavia, later Serbia and Montenegro (until 2006)A
NO912851D0NorwayD0
HUT56493AHungaryA
HU204701BHungaryB
EP0261402B1European Patent Office (EPO)B1
AT73677TAustriaT
ATE73677T1This recordAustriaT1
DE3777511D1GermanyD1
ES2030026T3SpainT3
CS623787A3Czechoslovakia (until 1993)A3
CA1312800CCanadaC
GR3004404T3GreeceT3
CZ277739B6CzechiaB6
IL83668AIsraelA
PL161466B1PolandB1
NO173168BNorwayB
NO173168CNorwayC
IE61305B1IrelandB1
HRP920853A2CroatiaA2
FI95539BFinlandB
FI95539CFinlandC
SI8711587ASloveniaA
NO302102B1NorwayB1
YU48299BYugoslavia, later Serbia and Montenegro (until 2006)B
JP2763773B2JapanB2
US5820876AUnited States of AmericaA
HRP920853B1CroatiaB1
US6110488AUnited States of AmericaA
US6117448AUnited States of AmericaA
US6126963AUnited States of AmericaA
US6139868AUnited States of AmericaA
US6224900B1United States of AmericaB1
US6264977B1United States of AmericaB1
USRE37934EUnited States of AmericaE
DK175077B1DenmarkB1